RITUKSIMAB PRI PERVIChNOJ IMMUNOLOGIChESKOJ TROMBOCITOPENII - U wzroslyh. DE

Lechenie nekotoryh refrakternyh i kortikorezistentnyh form ITP chasto predstawlqet soboj terapewticheskuü problemu. Poqwlenie nowyh terapewticheskih al'ternatiw, w chastnosti bioterapii, otkrylo nowye wozmozhnosti dlq dostizheniq remissii u ätih pacientow. Rituximab qwlqetsq bioterapiej wybora w takih situaciqh. My izuchili pokazaniq k primeneniü rituximaba, a takzhe terapewticheskij otwet u pacientow s hronicheskim refrakternym ITP. Na osnowe nashego opyta i obzora literatury my postaraemsq napomnit' o patofiziologii, klinicheskih i biologicheskih osobennostqh ITP, izuchit' pokazaniq i primenenie rituximaba pri ITP i rasskazat' o drugih bioterapiqh, primenqemyh pri ITP, i ih pokazaniqh.

Info autore

Dr. Chifa Damak is a university hospital assistant in internal medicine at the Department of Internal Medicine of Sfax and the Faculty of Medicine of Sfax.

Dettagli sul prodotto

• Autori: Zouhir Bahloul, Chifa Damak, Mouna Guermazi
• Editore: Sciencia Scripts
• Lingue: Russo
• Formato: Tascabile
• Pubblicazione: 26.11.2022
• EAN: 9786205393543
• ISBN: 9786205393543
• Pagine: 56
• Categoria: Scienze naturali, medicina, informatica, tecnica > Medicina > Branche non cliniche